Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases. The firm's product portfolio includes ACG-801 and ACG-701, which targets Farber Disease, Melioidosis, and Cystic Fibrosis. The company was founded in 1989 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Aceragen Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aceragen Inc market cap is $3.2M.
What is the 52-week high for Aceragen Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aceragen Inc 52 week high is $16.00 as of October 25, 2025.
What is the 52-week low for Aceragen Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aceragen Inc 52 week low is $0.3601 as of October 25, 2025.
What is the PE ratio of Aceragen Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aceragen Inc’s P/E ratio is -0.07.
What is the Price-to-Book ratio of Aceragen Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aceragen Inc P/B ratio is 0.0635.
What is the 50-day moving average of Aceragen Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aceragen Inc 50-day moving average is $1.06.
